A156100 Share Price Performance
₩7,140.00
-910.00 (-11.30%)
Price ₩7,140.00
Share Price₩7,140.00
A156100 Community Narratives
There are no narratives available yet.
Recent A156100 News & Updates
No updates
L&K Biomed Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 278.84
- Gross Margin
- 82.21%
- Net Profit Margin
- 15.55%
- Debt/Equity Ratio
- 61.0%
L&K Biomed Ltd. Competitors
About A156100
- Founded
- 2008
- Employees
- 91
- CEO
- WebsiteView website
L&K Biomed Ltd., a medical company, manufactures and sells spinal implants worldwide. It offers advanced lateral cage system for spinal lordosis restoration; anterior and expandable lateral lumber cage systems; cervical interbody fusion cage, anterior cervical plate system, posterior cervical fixation system; spinal fixation screw, lumber plate, and spinal fixation systems, as well as posterior lumber interbody cage. The company also provides lateral and anterior lumber interbody cage, and transforaminal lumber interbody cage; MIS spinal and spinal fixation systems; and SI joint fusion system. L&K Biomed Ltd. was founded in 2008 and is headquartered in Yongin-si, South Korea.
South Korean Market Performance
- 7 Days: -1.1%
- 3 Months: 22.2%
- 1 Year: 23.5%
- Year to Date: 30.6%
Over the past 7 days, the market has dropped 1.1% with the Materials sector contributing the most to the decline. In contrast to the last week, the market is actually up 24% over the past year. Earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading